BVT Aktienanleihe OMV 27.06.2025/ DE000VM79F00 /
9/26/2024 8:47:52 AM | Chg.-0.76 | Bid11:05:34 AM | Ask11:05:34 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
98.12EUR | -0.77% | 97.99 Bid Size: 500,000 |
98.09 Ask Size: 500,000 |
OMV AG | 40.00 EUR | 6/27/2025 | Call |
GlobeNewswire
3/26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
1/16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
9/14/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
10/13/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center